Acetylation of p53 Inhibits Its Ubiquitination by Mdm2
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
In response to DNA damage, the activity of the p53 tumor suppressor is modulated by protein stabilization and post-translational modifications including acetylation. Interestingly, both acetylation and ubiquitination can modify the same lysine residues at the C terminus of p53, implicating a role of acetylation in the regulation of p53 stability. However, the direct effect of acetylation on Mdm2-mediated ubiquitination of p53 is still lacking because of technical difficulties. Here, we have developed a method to obtain pure acetylated p53 proteins from cells, and by using an in vitro purified system, we provide the direct evidence that acetylation of the C-terminal domain is sufficient to abrogate its ubiquitination by Mdm2. Importantly, even in the absence of DNA damage, acetylation of the p53 protein is capable of reducing the ubiquitination levels and extending its half-life in vivo. Moreover, we also show that acetylation of p53 can affect its ubiquitination through other mechanisms in addition to the site competition. This study has significant implications regarding a general mechanism by which protein acetylation modulates ubiquitination-dependent proteasome proteolysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“upon DNA damage, p53 becomes acetylated at multiple residues within its C-terminal domain to stabilize the protein via directly blocking ubiquitination at acetylated sites as well as hindering the interaction between p53 and MDM2 to discourage ubiquitination at unacetylated sites [47,48].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [48]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Self-citationDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Self-citationThe HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,780
Research works printed but not linked: 1
- Appella, 2000, Pathol. Biol. (Paris), 48, 227
Cited by
Items 301–400 of 520
Behind the scenes: Unravelling the molecular mechanisms of p53 target gene selectivity (Review)
Lohrum (2010) · International Journal of Oncology · doi:10.3892/ijo_00000757 · Cited by 30
Rana, S., Datta, R., Chaudhuri, R. D., Chatterjee, E., Chawla‐Sarkar, M., & Sarkar, S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7371 · Cited by 25
Knights, C. D., Liu, Y., Appella, E., & Kulesz-Martin, M. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300279200 · Cited by 26
Li, Y., Li, S., Shi, X., Xin, Z., Yang, Y., Zhao, B., Li, Y., Lv, L., Ren, P., & Wu, H. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05824-x · Cited by 25
Lessons from interconnected ubiquitylation and acetylation of p53: think metastable networks
Benkirane, M., Sardet, C., & Coux, O. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380098 · Cited by 27
Yang, P., Huang, W., Lin, Y., Huang, W., Wu, H., Chen, W., Chang, Y., Chou, C., Tzeng, C., Chen, Y., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00712.x · Cited by 26
Novel hypoxia-induced HIF-1αactivation in asthma pathogenesis
Wan, M., Yu, Q., Xu, F., You, L. X., Liang, X., Ren, K., & Zhou, J. (2024) · Respiratory Research · doi:10.1186/s12931-024-02869-0 · Cited by 23
Inauhzin Sensitizes p53-Dependent Cytotoxicity and Tumor Suppression of Chemotherapeutic Agents
Zhang, Y., Zhang, Q., Zeng, S. X., Hao, Q., & Lu, H. (2013) · Neoplasia · doi:10.1593/neo.13142 · Cited by 24
VorinostatSAHA Promotes Hyper-Radiosensitivity in Wild Type p53 Human Glioblastoma Cells.
Diss, E., Nalabothula, N., Nguyen, D. M., Chang, E., Kwok, Y., & Carrier, F. (2014) · PubMed · Cited by 23
Wei, J., Dong, S., Yao, K., Martinez, M. F. Y. M., Fleisher, P. R., Zhao, Y., Ma, H., & Zhao, J. (2018) · The FASEB Journal · doi:10.1096/fj.201701069r · Cited by 23
Ray, P., Raghunathan, K., Ahsan, A., Allam, U. S., Shukla, S., Basrur, V., Veatch, S. L., Lawrence, T. S., Nyati, M. K., & Ray, D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013519 · Cited by 23
Šoštarić, N., & van Noort, V. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008988 · Cited by 23
The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Jiang, H., Luo, J., & Lei, H. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2021.108910 · Cited by 23
Self-citationSivakumar, K. K., Stanley, J. A., Behlen, J. C., Wuri, L., Dutta, S., Wu, J., Arosh, J. A., & Banu, S. K. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.03.007 · Cited by 22
Poulin, D. L., & DeCaprio, J. A. (2006) · Virology · doi:10.1016/j.virol.2006.01.046 · Cited by 22
Kokate, S. B., Dixit, P., Das, L., Rath, S., Roy, A. D., Poirah, I., Chakraborty, D., Rout, N., Singh, S. P., & Bhattacharyya, A. (2018) · The FASEB Journal · doi:10.1096/fj.201701344rrr · Cited by 25
Bi, X., Ye, Q., Li, D., Peng, Q., Wang, Z., Wu, X. B., Zhang, Y., Zhang, Q., & Jiang, F. (2019) · Aging Cell · doi:10.1111/acel.12900 · Cited by 22
The MDM2–p53 pathway: multiple roles in kidney development
El-Dahr, S. S., Hilliard, S. A., Aboudehen, K., & Saifudeen, Z. R. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2629-y · Cited by 21
Inhibiting p53 Acetylation Reduces Cancer Chemotoxicity
Zheng, S., Koh, X. Y., Goh, H. C., Rahmat, S. A. B., Hwang, L., & Lane, D. P. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0424 · Cited by 22
Sankunny, M., & Eng, C. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0094-x · Cited by 21
Acetylation of C-terminal lysines modulates protein turnover and stability of Connexin-32
Alaei, S. R., Abrams, C. K., Bulinski, J. C., Hertzberg, E. L., & Freidin, M. M. (2018) · BMC Cell Biology · doi:10.1186/s12860-018-0173-0 · Cited by 21
Acetylation of NDPK-D Regulates Its Subcellular Localization and Cell Survival
Fujita, Y., Fujiwara, K., Zenitani, S., & Yamashita, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139616 · Cited by 22
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
New Insights into the Role of Histone Deacetylases as Coactivators of Inflammatory Gene Expression
Schmitz, M. L., & de la Vega, L. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5750 · Cited by 20
Histone Modifications: Implications in Renal Cell Carcinoma
Ramakrishnan, S., Ellis, L., & Пили, Р. (2013) · Epigenomics · doi:10.2217/epi.13.40 · Cited by 23
Kaur, I., Rawal, P., Rohilla, S., Bhat, M. H., Sharma, P., Siddiqui, H., & Kaur, S. (2018) · Cell Biology International · doi:10.1002/cbin.10999 · Cited by 21
Acetylation of calmodulin regulates synaptic plasticity and fear learning
Zhang, H., Zhao, B. T., Han, W., Sun, Y.-B., Yang, P., Chen, Y., Ni, D., Zhang, J., & Yin, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101034 · Cited by 22
HEXIM1, a New Player in the p53 Pathway
Lew, Q. J., Chu, K., Chia, Y. L., Cheong, N., & Chao, S. (2013) · Cancers · doi:10.3390/cancers5030838 · Cited by 20
Choi, J.-R., Lee, S.-Y., Shin, K. S., Choi, C. Y., & Kang, S. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-16489-w · Cited by 20
Regulation of p53-dependent transcription
Jõers, A. (2004) · DSpace repository (University of Tartu) · Cited by 248
Epidermal Growth Factor Receptor activation promotes ADA3 acetylation through the AKT-p300 pathway
Srivastava, S., Mohibi, S., Mirza, S., Band, H., & Band, V. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1339846 · Cited by 19
Discovery and characterization of Ku acetylation in Mycobacterium smegmatis
Zhou, Y., Chen, T., Zhou, L., Fleming, J., Deng, J., Wang, X., Wang, L., Wang, Y., Zhang, X., Wei, W., et al. (2014) · FEMS Microbiology Letters · doi:10.1093/femsle/fnu051 · Cited by 19
Laguesse, S., Close, P., Hees, L. V., Chariot, A., Malgrange, B., & Nguyen, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00122 · Cited by 19
p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR
Usluer, S., Spreitzer, E., Bourgeois, B. M. R., & Madl, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111431 · Cited by 19
Bo, M. D., D’Agaro, T., Gobessi, S., Zucchetto, A., Dereani, S., Rossi, D., Zaja, F. F., Pozzato, G., Raimondo, F. D., Gaïdano, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3905 · Cited by 21
Karasawa, Y., & Okisaka, S. (2004) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-004-0122-7 · Cited by 19
Tickets for p53 journey among organelles
Ferecatu, I., Rincheval, V., Mignotte, B., & Vayssiere, J.-L. (2009) · Frontiers in bioscience · doi:10.2741/3524 · Cited by 19
Lysines in the tetramerization domain of p53 selectively modulate G1 arrest
Beckerman, R., Yoh, K. E., Mattia-Sansobrino, M., Zupnick, A., Laptenko, O., Karni-Schmidt, O., Ahn, J., Byeon, I. L., Keezer, S. M., & Prives, C. L. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1170270 · Cited by 20
Wittlinger, M., Grabenbauer, G. G., Sprung, C. N., Sauer, R., & Distel, L. V. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701275432 · Cited by 23
Functional investigations of p53 acetylation enabled by heterobifunctional molecules
Chen, L.-Y., Singha Roy, S. J., Jadhav, A. M., Wang, W. W., Chen, P.-H., Bishop, T., Erb, M. A., & Parker, C. G. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00438 · Cited by 18
Kienle, S. M., Schneider, T., Stuber, K., Globisch, C., Jansen, J., Stengel, F., Peter, C., Marx, A., Kovermann, M., & Scheffner, M. (2022) · Nature Communications · doi:10.1038/s41467-022-33087-1 · Cited by 20
Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity
Yu, S., Tang, R.-C., Zhang, A., Geng, S., Yu, H., Zhang, Y., Sun, X., & Zhang, J. (2024) · Journal of Virology · doi:10.1128/jvi.00088-24 · Cited by 18
Bourthoumieu, S., Magnaudeix, A., Terro, F., Lévêque, P., Collin, A., & Yardin, C. (2012) · Bioelectromagnetics · doi:10.1002/bem.21744 · Cited by 19
Control of apoptosis by SMAR 1
Malik, M. Z., Alam, M. J., Ishrat, R., Agarwal, S. M., & Singh, R. K. B. (2016) · Molecular BioSystems · doi:10.1039/c6mb00525j · Cited by 20
Kusio-Kobiałka, M., Wolanin, K., Podszywalow‐Bartnicka, P., Sikora, E., Skowronek, K., McKenna, S. L., Ghizzoni, M., Dekker, F. J., & Piwocka, K. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0739-9 · Cited by 19
Maspin increases Ku70 acetylation and Bax-mediated cell death in cancer cells
Park, C. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.833 · Cited by 18
Modulating the p53-MDM2 pathway: the therapeutic potential of natural compounds in cancer treatment
Ramli, I., Cheriet, T., Posadino, A. M., Giordo, R., Fenu, G., Nwachukwu, K. C., Oyewole, O. A., Adetunji, C. O., Călina, D. C., Sharifi-Rad, J., et al. (2024) · EXCLI journal · doi:10.17179/excli2024-7791 · Cited by 28
BK channel deacetylation by SIRT1 in dentate gyrus regulates anxiety and response to stress
Yu, D., Homiack, D., Sawyer, E. J., & Schrader, L. A. (2018) · Communications Biology · doi:10.1038/s42003-018-0088-5 · Cited by 17
Xu, X., Zhang, C., Xu, H., Wu, L., Hu, M., & Song, L. (2020) · Journal of Cell Science · doi:10.1242/jcs.246868 · Cited by 19
Orphan Nuclear Receptor PNR/NR2E3 Stimulates p53 Functions by Enhancing p53 Acetylation
Wen, Z. H., Pyeon, D., Wang, Y., Lambert, P. F., Xu, W., & Ahlquist, P. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05513-11 · Cited by 17
Lee, H., Jung, T.-Y., Lim, S. H., Choi, E. J., Lee, J., & Min, D. S. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00659-y · Cited by 16
Increased stability of heterogeneous ribonucleoproteins by a deacetylase inhibitor
Koumbadinga, G. A., Mahmood, N., Lei, L., Kan, Y., Cao, W., Lobo, V. G., Yao, X., Zhang, S., & Xie, J. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.05.001 · Cited by 17
Bao‐Lei, T., Zhuzhong, M., Song, Y., Jun‐Jie, Q., Yan, D., Hua, L., Bin, L., Zhao, G., & Zhi‐Xian, S. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20584 · Cited by 18
Cuenca‐Bermejo, L., Prinetti, A., Kublickiene, K. R., Raparelli, V., Kautzky‐Willer, A., Norris, C. M., Pilote, L., & Herrero, M. T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15834 · Cited by 17
The Dynamics of Stress p53-Mdm2 Network Regulated by p300 and HDAC1
Arora, A., Gera, S., Maheshwari, T., Raghav, D., Alam, M. J., Singh, R. K. B., & Agarwal, S. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052736 · Cited by 16
Targeted Protein Acetylation Through Chemically Induced Proximity
Wang, W., Roy, S. J. S., & Parker, C. G. (2025) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5c00326 · Cited by 14
Yang, T., Chen, X., Jin, H., Sethi, G., & Go, M. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.027 · Cited by 14
O’Neill, W. Q., Xie, X., Gui, S., Yu, H., Davenport, J., Cartwright, T., Storl-Desmond, M., Ryu, E., Chan, E. R., Cao, S., et al. (2022) · Cancers · doi:10.3390/cancers14020282 · Cited by 14
Decoding post‐translational modifications of mammalian septins
Sharma, K., & Menon, M. B. (2023) · Cytoskeleton · doi:10.1002/cm.21747 · Cited by 14
Emam, A. A., Arbon, D., Jeeves, M., & Kysela, B. P. (2018) · Neoplasma · doi:10.4149/neo_2018_171020n673 · Cited by 14
Kwon, Y., Kwon, T.-U., Shin, S., Lee, B., Lee, H. G., Park, H., Kim, D., Moon, A., & Chun, Y. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166868 · Cited by 14
Won, J., Chung, S. Y., Kim, S. B., Byun, B. H., Yoon, Y. S., & Joe, C. O. (2006) · Molecules and Cells · doi:10.1016/s1016-8478(23)12883-4 · Cited by 14
Acronyms (2012) · Legal Abbreviations and Acronyms · Cited by 13
TRRAP-mediated acetylation on Sp1 regulates adult neurogenesis
Yin, B.-K., Lázaro, D., & Wang, Z. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.024 · Cited by 12
MDM2 Implications for Potential Molecular Pathogenic Therapies of Soft-Tissue Tumors
Sun, S. Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113638 · Cited by 14
Xu, D., Qian, W., Yang, Z., Zhang, Z., Sun, P., Wan, Q., Yin, Y., Hu, Y., Gong, L., Zhang, B., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107003 · Cited by 14
Fu, P., Zhu, R., Gao, W., & Gong, L. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18096 · Cited by 12
SCF FBXW17 E3 ubiquitin ligase regulates FBXL19 stability and cell migration
Dong, S., Wei, J., Bowser, R. K., Chen, B. B., Mallampalli, R. K., Miao, J., Ye, Q., Tran, K. C., Zhao, Y., & Zhao, J. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29860 · Cited by 12
Acetylation of Endogenous STAT Proteins
Ginter, T., Heinzel, T., & Krämer, O. H. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-242-1_12 · Cited by 13
Smad1 Promotes Tumorigenicity and Chemoresistance of Glioblastoma by Sequestering p300 From p53
Gong, L., Xu, D., Ni, K., Li, J., Mao, W., Zhang, B., Pu, Z., Fang, X., Yin, Y., Li, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202402258 · Cited by 13
RETRACTED: High‐Resolution Imaging of Human Cancer Proteins Using Microprocessor Materials
Solares, M. J., Jonaid, G. M., Luqiu, W. Y., Berry, S., Khadela, J., Liang, Y., Evans, M. C., Pridham, K. J., Dearnaley, W. J., Sheng, Z., et al. (2022) · ChemBioChem · doi:10.1002/cbic.202200310 · Cited by 12
RetractedAlaee, M., Padda, A., Mehrabani, V., Churchill, L., & Pasdar, M. (2016) · Oncotarget · doi:10.18632/oncotarget.8616 · Cited by 11
Characterization of the class IIa histone deacetylases substrate specificity
Kutil, Z., Meleshin, M., Baranova, P., Havlinova, B., Schutkowski, M., & Bařinka, C. (2022) · The FASEB Journal · doi:10.1096/fj.202101663r · Cited by 11
P2X7 receptors and epithelial cancers
Gorodeski, G. I. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.33 · Cited by 11
Mechanisms of p53 activation and physiological relevance in the developing kidney
Aboudehen, K., Hilliard, S. A., Saifudeen, Z. R., & El-Dahr, S. S. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00642.2011 · Cited by 12
Gao, L., Li, Y., Yu, C., Liu, D., Wu, K., Wei, Z.-L., Liu, M., & Yu, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.847793 · Cited by 11
Bakhshi, T. J., Way, T., Muncy, B. C., & Georgel, P. T. (2023) · Biochemistry and Cell Biology · doi:10.1139/bcb-2022-0288 · Cited by 10
Tuz-Sasik, M. U., Karoglu-Eravsar, E. T., Kinali, M., Ergul, A. A., & Adams, M. M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.003 · Cited by 11
Muyskens, J. B., Winbush, A., Foote, D. M., Turnbull, D. W., & Dreyer, H. C. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00022.2020 · Cited by 10
Wang, W. L., Chen, L. J., Wei, S.-Y., Shih, Y. T., Huang, Y. H., Lee, P., Lee, C.-I., Wang, M.-C., Lee, D. Y., Chien, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.647714 · Cited by 10
Lai, C. W., Xie, C., Raufman, J., & Xie, G. (2022) · Cancers · doi:10.3390/cancers14010219 · Cited by 10
Maki, C. G. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_8 · Cited by 11
Yang, Y., Zheng, L., He, J., Wu, T., Yang, H., Zhang, B., Zhou, S., Lu, Y., He, X., Li, J., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07781-z · Cited by 9
High Throughput miRNA Screening Identifies miR-574-3p Hyperproductive Effect in CHO Cells
Švab, Ž., Braga, L., Guarnaccia, C., Labik, I., Herzog, J. S., Baralle, M., Giacca, M., & Skoko, N. (2021) · Biomolecules · doi:10.3390/biom11081125 · Cited by 9
Xie, Q., Hu, B., & Li, H. (2024) · Biology Direct · doi:10.1186/s13062-024-00480-3 · Cited by 9
Manav, N., Jit, B. P., Kataria, B., & Sharma, A. K. (2024) · Epigenomics · doi:10.1080/17501911.2024.2351788 · Cited by 11
Lodewick, J., Sampaio, C. S., Boxus, M., Rinaldi, A., Coulonval, K., Willems, L., Roger, P. P., & Bex, F. (2013) · Retrovirology · doi:10.1186/1742-4690-10-75 · Cited by 11
Window-of-Opportunity Study of Valproic Acid in Breast Cancer Testing a Gene Expression Biomarker
Cohen, A. L., Neumayer, L. A., Boucher, K. M., Factor, R. E., Shrestha, G., Wade, M. L., Lamb, J. G., Arbogast, K., Piccolo, S., Riegert, J., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.16.00011 · Cited by 10
Do p53 stress responses impact organismal aging?
Hasty, P., Campisi, J., & Sharp, Z. D. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.12.02 · Cited by 10
Targeting the Cancer Epigenome with Histone Deacetylase Inhibitors in Osteosarcoma
Collier, C. D., Getty, P. J., & Greenfield, E. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_4 · Cited by 10
Acetylation and alternative splicing regulate ZNF76-mediated transcription
Zheng, G., & Yang, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.122 · Cited by 9
Modulating Molecular Functions of p53 with Small Molecules
Mujtaba, S., Zeng, L., & Zhoug, M.-M. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3464 · Cited by 11
Iwakawa, H., Carter, B. C., Bishop, B., Ogas, J., & Gelvin, S. B. (2016) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi-12-16-0250-r · Cited by 9
Ji, S., Xu, X., Li, Y., Sun, S., Fu, Q., Qiu, Y., Wang, S., Xia, S., Wang, F., Zhang, F., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17121727 · Cited by 8
Zhou, Z., Zhong, L., Chu, X., Wan, P., Dan, W., Shao, X., Chen, S., Zhang, Z., Lu, Y., & Liu, B. (2023) · Medical Oncology · doi:10.1007/s12032-023-02196-2 · Cited by 8
Peptides meet ubiquitin: Simple interactions regulating complex cell signaling
Veggiani, G., & Sidhu, S. S. (2018) · Peptide Science · doi:10.1002/pep2.24091 · Cited by 8
p53 Tumor Suppressor: Functional Regulation and Role in Gene Therapy
Farooq, Z., Wani, S., Ragunathrao, V. A. B., Kochhar, R. K., & Anwar, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105029 · Cited by 8
Analysis of lysine acetylation in tomato spot wilt virus infection in Nicotiana benthamiana
Gong, Y., Li, Y., Liu, D., Jiang, L., Liang, H., Wu, Y., Wang, F., & Yang, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1046163 · Cited by 8
Acetylation of GAGA Factor Modulates Its Interaction with DNA
Aran-Guiu, X., Ortiz-Lombardía, M., de Oliveira, E., Bonet-Costa, C., Odena, M. A., Bellido, D., & Bernués, J. (2010) · Biochemistry · doi:10.1021/bi1004427 · Cited by 8
Acetylation of the nuclear localization signal in Ku70 diminishes the interaction with importin-α
Fujimoto, H., Ikuta, T., Koike, A., & Koike, M. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101418 · Cited by 8
Metadata
- Authors
- Li, M., Luo, J., Brooks, C. L., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 277
- Issue
- 52
- Pages
- 50607-50611
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082541302
- Cited by
- 503
- References
- 34
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 19 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 14 · 2019: 15 · 2018: 17 · 2017: 22 · 2016: 15 · 2015: 18 · 2014: 27 · 2013: 33 · 2012: 27
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6528 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (5-T32-CAO9503-17, T32CA009503)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53 acetylation, MDM2, ubiquitination, p53 stabilization, post-translational modification, DNA damage response, tumor suppressor regulation, site competition
- MeSH terms
- Acetylation, Animals, Burkitt Lymphoma, Cloning, Molecular, DNA Damage, HeLa Cells, Humans, Kinetics, Neoplasm Proteins, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Recombinant Proteins, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Ubiquitin, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.